Editas Medicine (EDIT) has received a new Buy rating, initiated by JonesTrading analyst, Soumit Roy. Soumit Roy has given his Buy rating due to ...
The software and cloud-native live production and editing platform says it dramatically reduces the cost of sports production ...
News Medical on MSN53m
MaxCyte signs strategic platform license with Kamau Therapeutics to accelerate the development of cell therapies for genetic diseasesMaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based ...
New Investment will Accelerate Transformative Innovation in Precision Plant Breeding, Improving Consumer Nutrition, Grower ...
Seven's strategic investment through its VC arm includes an option for a further $3m, used to increase its brand awareness ...
There are a jaw-dropping 5.35 billion internet users around the world. But you’d be surprised how many people are not aware of the free resources available to them. The post 52 Helpful Things On The ...
The funds will support ongoing work on Fulcrum, Pairwise's gene-editing platform and efforts to create edited crops with specific traits.
Investments from this funding round will be used to scale Pairwise’s innovative product pipeline, including seedless berries and pitless cherries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback